Jan-Mangal Pharmacy Foundation
About Jan-Mangal Pharmacy Foundation
Data last updated:
Jan-Mangal Pharmacy Foundation is a private not for profit company based in Valsad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U85320GJ2017NPL096400. Its GSTIN is 24AADCJ9244P1Z1 (Gujarat).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Hemanshu Lalitbhai Kapadia and Dhananjay Thakorbhai Desai.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Valsad, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹92.2 Lakh, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹12,199 (net margin 0.1%) and EBITDA of ₹76,894 (EBITDA margin 0.8%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years and 1% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Jan-Mangal Pharmacy Foundation's registered office is in Valsad, Gujarat. Its e-mail address is in the company report.
- Email
- Registered AddressC/O. Rnc Free Eye Hospital, Kacheri Road Dr. Paragji Desai Road Opp. Mamlatdar Office, Valsad, Gujarat, India – 396001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Jan-Mangal Pharmacy Foundation, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Jan-Mangal Pharmacy Foundation is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Jan-Mangal Pharmacy Foundation, buy the company report.
Financials of Jan-Mangal Pharmacy Foundation
FY 2025 filings availableJan-Mangal Pharmacy Foundation reported revenue of ₹92.2 Lakh (up 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 5% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA rose 261% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹76,894 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12,199 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.8% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jan-Mangal Pharmacy Foundation, buy the company report.
Board of directors of Jan-Mangal Pharmacy Foundation
Jan-Mangal Pharmacy Foundation has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hemanshu Lalitbhai Kapadia | Director | 21 Mar 2017 | 9 Years 7 Months | Current |
| Dhananjay Thakorbhai Desai | Director | 21 Mar 2017 | 9 Years 7 Months | Current |
| Japan Shah | Additional Director | 06 Dec 2025 | 0 Years 10 Months | Current |
| Jatinkumar Ranchhodbhai Patel Also directs: Bioquest Innovations LLP | Additional Director | 24 Jan 2026 | 0 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Jan-Mangal Pharmacy Foundation are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jan-Mangal Pharmacy Foundation; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Jan-Mangal Pharmacy Foundation has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AADCJ9244P1Z1 | Gujarat | Active | 04 May 2018 |
To see the full GST registrations and return filing status of Jan-Mangal Pharmacy Foundation, buy the company report.
Recent activity
Jan-Mangal Pharmacy Foundation has 10 board changes on record since 2017: 7 appointments and 3 cessations. The latest: Jatinkumar Ranchhodbhai Patel was appointed as Additional Director on 24 Jan 2026.
1 earlier event is in the company report.
Frequently asked questions
Jan-Mangal Pharmacy Foundation is an active private not for profit company based in Valsad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 March 2017 (9+ years old) and is registered under CIN U85320GJ2017NPL096400.
Jan-Mangal Pharmacy Foundation has 4 current directors:
- Hemanshu Lalitbhai Kapadia - Director
- Dhananjay Thakorbhai Desai - Director
- Japan Shah - Additional Director
- Jatinkumar Ranchhodbhai Patel - Additional Director
The latest financial statements of Jan-Mangal Pharmacy Foundation on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Jan-Mangal Pharmacy Foundation is 24AADCJ9244P1Z1, registered in Gujarat.
The CIN (Corporate Identification Number) of Jan-Mangal Pharmacy Foundation is U85320GJ2017NPL096400. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jan-Mangal Pharmacy Foundation was incorporated on 21 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Jatinkumar Ranchhodbhai Patel was appointed as Additional Director on 24 Jan 2026. Japan Shah was appointed as Additional Director on 06 Dec 2025. Ashokbhai Kantilal Patel ceased to be Additional Director on 15 Nov 2018. Jan-Mangal Pharmacy Foundation has 10 board changes on record in total.
The registered office of Jan-Mangal Pharmacy Foundation is at CO. Rnc Free Eye Hospital, Kacheri Road Dr. Paragji Desai Road Opp. Mamlatdar Office, Valsad, Gujarat, India – 396001.
Jan-Mangal Pharmacy Foundation operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Jan-Mangal Pharmacy Foundation is compliant as of 22 August 2026. The company is actively filing with the Registrar of Companies.